Repertoire® Immune Medicines Announces Strategic Collaboration with Lilly to Develop Tolerizing Therapies for Autoimmune Diseases
PR Newswire —
Collaboration unites Repertoire's DECODE™ platform to develop T cell targeted immune medicines with Lilly's commitment to bringing transformative medicines to patients with unmet need CAMBRIDGE, Mass., Jan. 29, 2026 /PRNewswire/ -- Repertoire® Immune Medicines, a biotechnology company...